Table 4.
diagnosis | psoriatic arthritis | normal | |||||
---|---|---|---|---|---|---|---|
patient | A | B | C | D | E | F | G |
sex | F | F | F | M | F | F | F |
age (years) | 53 | 39 | 52 | 55 | 42 | 70 | 57 |
disease duration (months) | 288 | 6 | 36 | 144 | 4 | - | - |
ESR (mm/1h) | 36 | 35 | 25 | 34 | 20 | 35 | 45 |
CRP (mg/L) | 20 | 11 | 1.6 | 4 | 0.14 | 6.4 | 6.8 |
RF (U/mL) | 42 | 10.6 | 2.6 | 17 | 5.9 | 6 | 42 |
anti-CCP (Um/L) | 27 | 9.2 | 5.5 | 10.9 | 10.3 | 5.4 | 5.8 |
polyarticular disease | yes | yes | yes | yes | yes | - | - |
treatment | δ + γ | δ | β | β | δ | - | - |
Abbreviations: F – female; M – male; δ – disease modifying anti-rheumatic drug; γ – glucocorticoids; β –biologic anti-inflammatory drugs. |